Orchestra BioMed Holdings Inc. (OBIO) stock news · rev $33.5M
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
This OBIO news page leads with what Orchestra BioMed Holdings Inc. filed — not a scraped headline mill.
No cached 8-K sentence for OBIO yet. We will not pad this page with generic market recap.
Latest reported OBIO revenue for 2025-12-31 was $33.5M. Net income was -$52.7M. Revenue was up 1169.2% from 2024-12-31 to 2025-12-31. OBIO currently screens at market cap $231.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the OBIO stock page; for the tape open the quote page.
OBIO stock news FAQ
What are OBIO's latest revenue and net income?
Latest cached Orchestra BioMed Holdings Inc. (OBIO) revenue for Dec 31, 2025 was $33.5M. Net income was -$52.7M. Statements: https://lician.com/financials/obio
How did OBIO revenue change from the prior cached period?
Cached Orchestra BioMed Holdings Inc. (OBIO) revenue was up 1169.2% from $2.6M (Dec 31, 2024) to $33.5M (Dec 31, 2025). Statements: https://lician.com/financials/obio
What is OBIO's market cap?
Orchestra BioMed Holdings Inc. (OBIO) market cap is $231.7M on the latest cached fundamentals snapshot.
What kind of company is OBIO?
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Where is OBIO stock news listed?
Cached stock news for Orchestra BioMed Holdings Inc. (OBIO) is listed at https://lician.com/news/obio. Filings: https://lician.com/sec/obio
Not investment advice.